Main Menu
VanNess & VanNess, P.A.
Toll Free: 866-697-6221 Local: 352-436-4333 Over 100 years of combined experience

FDA Approves New Treatment for Lung Cancer/Mesothelioma Patients

The United States Food and Drug Administration (FDA) recently approved Opdivo, an advanced lung cancer drug. Opdivo is the first immuno-oncology drug therapy for patients with lung cancer. Mesothelioma and lung cancer are caused by exposure and inhalation of dangerous asbestos fibers. Patients usually receive chemotherapy as their first choice of treatment to treat this difficult disease. However, Mesothelioma often reoccurs as it is considered chemo resistant, making the disease difficult to treat. Opdivo now offers patients a different treatment modality after chemotherapy. Dr. Suresh Ramalingam, M.D. Professor, Chief of Thoracic Oncology and Director of Medical Oncology, Winship Cancer Institute of Emory University, stated "This milestone brings to fruition the long held hope that immune-oncology medicines can be significantly effective in this difficult to treat population."

Know Your Rights

If you or a loved one have been diagnosed with Mesothelioma or lung cancer caused by exposure to asbestos it is important to know your rights. You have a right to compensation for your exposure to asbestos even though your exposure was years or even decades ago. Companies who manufactured products that contain dangerous asbestos fibers which you came in contact with, either directly or indirectly, are being held responsible for the dangerous effects of that exposure by courts across the country.

VanNess & VanNess, P.A.